^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

ADP-A2AFP

i
Other names: ADP-A2AFP, AFP T-cell therapy, Autologous genetically modified T-cells expressing affinity enhanced T-cell receptors (TCRs) specific for alpha fetoprotein, Autologous genetically modified AFPᶜ³³²T cells, AFPᶜ³³²T cell therapy, alpha fetoprotein targeted T-cell therapy, AFP SPEAR T-cell therapy, AFPᶜ³³²T, AFP TCR
Associations
Company:
Adaptimmune
Drug class:
TCR modulator
Related drugs:
Associations